Загрузка...
Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses
Everolimus (EVL) is a novel mTOR-inhibitor similar to sirolimus (SRL) that is used in organ transplant recipients, often in combination with tacrolimus (TAC) or mycophenolate (MPA). The current study aims to determine its effects on regulatory T cells. Increasing concentrations of EVL, MPA and TAC a...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898829/ https://ncbi.nlm.nih.gov/pubmed/27275747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0156535 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|